HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dc06-2563v1 30/4/993    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garg, R. Articles by Pendergrass, M. Search for Related Content PubMed PubMed Citation Articles by Garg, R. Articles by Pendergrass, M. Social Bookmarking                What's this?

Hyperglycemia and Length of Stay in Patients Hospitalized for Bone Marrow Transplantation

¹ Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts
² Division of Oncology, Brigham and Women's Hospital, Boston, Massachusetts

Address correspondence and reprint requests to Rajesh Garg, MD, Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, 221 Longwood Ave., Boston, MA 02115. E-mail: rgarg@partners.org

Abbreviations: BMT, bone barrow transplantation • LOS, length of stay

The first 20% of the full text of this article appears below.

	INTRODUCTION

 
Hyperglycemia has been shown to be associated with increased mortality and morbidity and prolonged hospital stay in inpatients (1–4). This association has been established for several conditions including cardiac surgery, acute myocardial infarction, stroke, trauma, burns, pneumonia, and critical illness (5–10). Good glycemic control has been shown to decrease length of stay (LOS) and save hospitalization costs (11,12). In randomized controlled trials of critically ill patients, the beneficial effects of good glycemic control were most prominent in those with longer hospitalizations and no previous history of diabetes (13).

Patients hospitalized for bone marrow transplantation (BMT) tend to be critically ill and have prolonged hospital stays. To our knowledge, there have been no previous reports that describe the relationship between blood glucose levels and LOS in patients admitted for BMT. This study was performed to establish the relationship between blood glucose and LOS in nondiabetic patients electively admitted for BMT.

	RESEARCH DESIGN AND METHODS—

 
A retrospective review of electronic medical records of patients electively admitted to the BMT unit between 1 January 2006 and 30 June 2006 was conducted. Patients were identified from the hospital admission/discharge data. Medical records were accessed to collect data on age, sex, date of admission, date of discharge, diabetes status, renal status, all available laboratory blood glucose . . . [Full Text of this Article]

	RESULTS—

 

	CONCLUSIONS—

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. L. Thompson and J. Duffy Nutrition Support Challenges in Hematopoietic Stem Cell Transplant Patients Nutr Clin Pract, October 1, 2008; 23(5): 533 - 546. [Abstract] [Full Text] [PDF]

				R. L. Derr, V. C. Hsiao, and C. D. Saudek Antecedent Hyperglycemia Is Associated With an Increased Risk of Neutropenic Infections During Bone Marrow Transplantation Diabetes Care, October 1, 2008; 31(10): 1972 - 1977. [Abstract] [Full Text] [PDF]